Development of low-dose reproductive hormone therapies in China

Xiang B L, 1978, Family Planning Drugs, 1, 77

Xiao B, 1983, China Popup News, 1, 1

Sang G W, 1996, Natl Med J Chin, 76, 325

Naftolin F, 2005, Climacteric medicine – Where do we go?, 4

10.1080/13697130400014615

Mattsson L A, 2003, Minerva Ginecol, 55, 201

Yasui T, 2003, J Med Invest, 50, 136

10.1016/S0378-5122(03)00141-5

10.1016/S0378-5122(02)00340-7

10.1385/ENDO:24:3:195

10.1016/j.fertnstert.2004.02.095

10.1016/j.maturitas.2005.02.016

Naftolin F, 2002, Menopause, 9, 1, 10.1097/00042192-200201000-00001

Du Z J, 1999, Acta Academiae Medicinae Sinicae, 21, 280

Nie M, 2001, Acta Academiae Medicinae Sinicae, 23, 485

He F F, 2000, J Reprod Med, 9, 71

Bjarnason N H, 1996, J Clin Endocrinal Metab, 81, 2419

10.1210/jcem.86.10.7937

Writing Group for the Women's Health Initiative Investigators, 2002, J Am Med Assoc, 288, 321, 10.1001/jama.288.3.321

Kuller L H, 2003, Arterioscler Thromb Vasc Biol, 23, 11, 10.1161/01.ATV.0000046033.32478.6D

Willett W C, 2006, Am J Epidemiol, 163, 1067, 10.1093/aje/kwj156

10.1097/00042192-199906030-00015

10.1016/S0015-0282(01)01792-7

Richman S, 2006, Menopause, 13, 148, 10.1097/01.gme.0000191205.20738.01

Hersh A L, 2004, J Am Med Assoc, 291, 47, 10.1001/jama.291.1.47

10.1016/S0015-0282(01)01829-5

10.1080/13697130600647743

10.1016/S0015-0282(01)01828-3

10.1001/jama.287.20.2668

Herbert C, Stary M D. Atlas of atherosclerosis, progression and regression. 2nd edn. Parthenon Publishing, New York 2003; 16–18